We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
869
Increased
2,214
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.37%
2 Healthcare 7.45%
3 Consumer Discretionary 5.14%
4 Industrials 5.1%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCFA.WS
5501
CALL
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$31.2K ﹤0.01%
260,000
ACRO.WS
5502
CALL
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$31.1K ﹤0.01%
357,430
NETC.WS
5503
CALL
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$31K ﹤0.01%
194,000
DISAW
5504
CALL
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$30.7K ﹤0.01%
334,131
NKTX icon
5505
Nkarta
NKTX
$154M
$30.5K ﹤0.01%
13,943
-58
-0.4% -$255
NFYS.WS
5506
CALL
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$30K ﹤0.01%
600,000
BGMS
5507
Bio Green Med Solution Inc
BGMS
$5.04M
$29.8K ﹤0.01%
14
-19
-58% -$42.4K
FRBNW
5508
CALL
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
$29.7K ﹤0.01%
69,000
DCX
5509
Digital Currency X Technology Inc
DCX
$436M
0
TMQ
5510
Trilogy Metals
TMQ
$549M
$29.1K ﹤0.01%
48,982
-474,751
-91% -$268K
CMPOW
5511
CALL
DELISTED
CompoSecure Inc Warrant
CMPOW
$28.9K ﹤0.01%
27,500
KRRO icon
5512
Korro Bio
KRRO
$151M
$28.8K ﹤0.01%
1,666
+681
+69% +$13.2K
BIOL
5513
DELISTED
Biolase, Inc.
BIOL
$28.8K ﹤0.01%
+4,068
New +$68.1K
BSAQ.WS
5514
CALL
DELISTED
Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BSAQ.WS
$28.7K ﹤0.01%
183,850
PLMJW
5515
CALL
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
$28.1K ﹤0.01%
678,496
MNPR icon
5516
Monopar Therapeutics
MNPR
$768M
$28K ﹤0.01%
+6,552
New +$33.5K
CANO
5517
CALL
DELISTED
Cano Health, Inc.
CANO
$27.8K ﹤0.01%
200
-5,000
-96% -$642K
MBOT icon
5518
Microbot Medical
MBOT
$117M
$27.8K ﹤0.01%
10,219
-4,643
-31% -$9.3K
ASBPW
5519
CALL
Aspire Biopharma Warrant
ASBPW
$447K
$27.6K ﹤0.01%
550,000
GURE
5520
Gulf Resources
GURE
$4.65M
$27.1K ﹤0.01%
1,091
-2,689
-71% -$74.4K
APGB.WS
5521
CALL
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$26.6K ﹤0.01%
217,314
+23,374
+12% +$3.02K
FRXB.WS
5522
CALL
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$26.4K ﹤0.01%
175,850
-29,000
-14% -$4.6K
BWAY
5523
Brainsway
BWAY
$612M
$26.1K ﹤0.01%
+22,998
New +$20.6K
KCGI.WS
5524
CALL
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$26.1K ﹤0.01%
327,759
CANO.WS
5525
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$25.8K ﹤0.01%
122,909

Similar funds

Millennium Management's Q2 2023 Portfolio in Review

As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
  • Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.